International partnership to advance the clinical development of a new vaccine against Shigella and ETEC

​

Horizon2020 award to consortium will support the testing of an innovative live attenuated vaccine in phase I clinical trials in Europe and Bangladesh.

EVI and Hilleman Laboratories announce partnership to assess a new vaccine against Shigella

​

Funding from EDCTP will allow testing of a novel whole-cell inactivated oral vaccine in clinical trials in Europe and Africa